FR6928M - - Google Patents

Info

Publication number
FR6928M
FR6928M FR129489A FR129489A FR6928M FR 6928 M FR6928 M FR 6928M FR 129489 A FR129489 A FR 129489A FR 129489 A FR129489 A FR 129489A FR 6928 M FR6928 M FR 6928M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR129489A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR129489A priority Critical patent/FR6928M/fr
Priority to BE710483D priority patent/BE710483A/xx
Priority to DE19681668933 priority patent/DE1668933A1/de
Priority to GB02757/68A priority patent/GB1175808A/en
Application granted granted Critical
Publication of FR6928M publication Critical patent/FR6928M/fr
Priority to DE19702016934 priority patent/DE2016934A1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR129489A 1967-11-24 1967-11-24 Expired FR6928M (is")

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR129489A FR6928M (is") 1967-11-24 1967-11-24
BE710483D BE710483A (is") 1967-11-24 1968-02-07
DE19681668933 DE1668933A1 (de) 1967-11-24 1968-02-10 In 3-Stellung substituierte 4-Hydroxycumarine
GB02757/68A GB1175808A (en) 1967-11-24 1968-03-15 Improvements in or relating to new Therapeutic Composition, new Coumarin Derivatives and their process of preparation
DE19702016934 DE2016934A1 (en) 1967-11-24 1970-04-09 4-hydroxycoumarine anticoagulants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR129489A FR6928M (is") 1967-11-24 1967-11-24

Publications (1)

Publication Number Publication Date
FR6928M true FR6928M (is") 1969-05-05

Family

ID=8642199

Family Applications (1)

Application Number Title Priority Date Filing Date
FR129489A Expired FR6928M (is") 1967-11-24 1967-11-24

Country Status (3)

Country Link
BE (1) BE710483A (is")
FR (1) FR6928M (is")
GB (1) GB1175808A (is")

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048090B1 (es) * 1992-01-31 1994-10-01 Rovi Lab Farmaceut Sa Procedimiento para la obtencion de nuevos antitromboticos derivados de la cumarina.
WO1996031206A2 (en) * 1995-04-07 1996-10-10 Warner-Lambert Company Flavones and coumarins as agents for the treatment of atherosclerosis
US8093273B2 (en) 2004-10-20 2012-01-10 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
JP5368792B2 (ja) 2005-07-29 2013-12-18 レスバーロジックス コーポレイション 複合疾患の予防および処置のための薬学的組成物および挿入可能な医療用デバイスによるその送達
PL2118074T3 (pl) 2007-02-01 2014-06-30 Resverlogix Corp Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego
AU2009262252B2 (en) 2008-06-26 2013-05-02 Resverlogix Corp. Methods of preparing quinazolinone derivatives
EP2382194B1 (en) 2009-01-08 2014-03-12 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
CN105859639A (zh) 2009-03-18 2016-08-17 雷斯韦洛吉克斯公司 新的抗炎剂
MX352614B (es) 2009-04-22 2017-12-01 Resverlogix Corp Nuevos agentes anti-inflamatorios.
ES2745471T3 (es) 2011-11-01 2020-03-02 Resverlogix Corp Formulaciones orales de liberación inmediata para quinazolinonas sustituidas
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
KR20150096794A (ko) 2012-12-21 2015-08-25 제니쓰 에피제네틱스 코포레이션 브로모도메인 저해제로서의 신규한 헤테로사이클릭 화합물
KR102662814B1 (ko) 2015-03-13 2024-05-03 리스버로직스 코퍼레이션 보체 관련 질환을 치료하기 위한 조성물 및 치료 방법

Also Published As

Publication number Publication date
GB1175808A (en) 1969-12-23
BE710483A (is") 1968-06-17

Similar Documents

Publication Publication Date Title
AU5765369A (is")
AT298283B (is")
FR6928M (is")
AU610966A (is")
BE710168A (is")
BE711163A (is")
BE711806A (is")
BE711650A (is")
BE711506A (is")
BE711198A (is")
BE710079A (is")
BE709891A (is")
BE709584A (is")
BE709497A (is")
BE709388A (is")
BE709383A (is")
BE709036A (is")
BE708980A (is")
BE705693A (is")
BE702123A (is")
BE701811A (is")
BE700153A (is")
BE693190A (is")
BE693127A (is")
BE693075A (is")

Legal Events

Date Code Title Description
ST Notification of lapse